Compile Data Set for Download or QSAR
maximum 50k data
Found 241 Enz. Inhib. hit(s) with all data for entry = 11327
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607941(US11691963, Example I-104)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607942(US11691963, Example I-105)
Affinity DataKd:  525nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607943(US11691963, Example I-106)
Affinity DataKd:  525nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607944(US11691963, Example I-108)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607945(US11691963, Example I-109)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607946(US11691963, Example I-110)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607947(US11691963, Example I-111)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607948(US11691963, Example I-112-a)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607949(US11691963, Example I-112-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607950(US11691963, Example I-113)
Affinity DataKd:  30nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607951(US11691963, Example I-114)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607952(US11691963, Example I-115)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607953(US11691963, Example I-116)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607954(US11691963, Example I-117-a)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607955(US11691963, Example I-117-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607956(US11691963, Example I-118)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607957(US11691963, Example I-119)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607958(US11691963, Example I-120)
Affinity DataKd:  30nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607959(US11691963, Example I-121)
Affinity DataKd:  30nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607960(US11691963, Example I-122)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607961(US11691963, Example I-123)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607962(US11691963, Example I-124)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607963(US11691963, Example I-125)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607964(US11691963, Example I-126)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607965(US11691963, Example I-127)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607966(US11691963, Example I-128-a)
Affinity DataKd:  525nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607967(US11691963, Example I-128-b)
Affinity DataKd:  525nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607968(US11691963, Example I-129-a)
Affinity DataKd:  30nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607969(US11691963, Example I-129-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607970(US11691963, Example I-130)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607971(US11691963, Example I-131)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607972(US11691963, Example I-132)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM607973(US11691963, Example I-133)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608023(US11691963, Example I-176-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608024(US11691963, Example I-177)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608025(US11691963, Example I-178)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608026(US11691963, Example I-179)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608027(US11691963, Example I-180)
Affinity DataKd:  30nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608028(US11691963, Example I-181)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608029(US11691963, Example I-182)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608030(US11691963, Example I-183)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608031(US11691963, Example I-184)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608032(US11691963, Example I-185)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608033(US11691963, Example I-186)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608034(US11691963, Example I-187-a)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608035(US11691963, Example I-187-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608036(US11691963, Example I-188)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608037(US11691963, Example I-189-a)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608038(US11691963, Example I-189-b)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Homo sapiens (Human))
Ajax Therapeutics

US Patent
LigandPNGBDBM608039(US11691963, Example I-190-a)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1domain-catalytic, Y1007F,Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HEK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 241 total ) | Next | Last >>
Jump to: